Date
25 June 2026Location
Online, via Webex, 13.00-14.00pmAbout the event
Speakers from South West Regional Homecare and NHS SPS provided insights to support planning and implementation of biosimilar and key generic medicines.
This webinar was intended for NHS procurement and clinical teams implementing biosimilar and high value generic medicines. It was not recorded as some information is commercially confidential and subject to change.
Why it’s important
Implementation of biosimilar and key generic medicines requires collaborative working across the system. The use of biological medicines, including biosimilars, is expanding in clinical practice.
Timely implementation and use of biosimilar and key generic medicines offers the NHS opportunities to deliver better value for certain conditions.
What was covered
- Information to support system planning and mobilisation for ruxolitinib and ferric carboxymaltose and aripiprazole generic medicines
- Key homecare considerations associated with the introduction of biosimilar and generic medicines
- A question and answer session
Speakers
A range of speakers from SPS and other organisations helped run this event.
Non-SPS speakers
Sarah Griffiths
South West Pharmacy Homecare and Procurement Specialist
SPS speakers
Learn more about our SPS team below
Resources
This webinar was intended for NHS procurement and clinical teams implementing biosimilar and high value generic medicines. It was not recorded as some information is commercially confidential and subject to change.
Contact us
Please contact the admin team if you have any questions.
Update history
- Amended to past event
- Admin email updated
- Published